Frost Health LawAlabama Attorney • Pharmacist • Healthcare Executive

PBM • Pharmacy Audits • Congressional Oversight • Enterprise Risk

House Oversight Examines Whether PBM Audits Targeted Pharmacy Advocates

House Oversight Chairman James Comer requested records from CVS Caremark, Express Scripts, and Optum Rx on October 23 concerning possible retaliation against independent pharmacies that supported H.R. 6610. The letters seek audit-selection methods, provider agreements, audit totals, and detailed records for three states. Requested briefings are due October 30 and documents November 6. These requests are directed to the PBMs. The inquiry does not decide whether retaliation occurred. Pharmacy leaders can use the development to review how they document notices, deadlines, communications, and outcomes.

By Toby C. “Chad” Frost • October 26, 2026
1 min read

What the committee requested

On October 23, 2026, House Oversight Chairman James Comer sent letters to CVS Caremark, Express Scripts, and Optum Rx concerning possible retaliatory audits of independent pharmacies that supported H.R. 6610. The committee seeks records and briefings to examine its concerns. The announcement describes an investigation, not an adjudicated finding of retaliation.1

The letters request provider manuals and agreements, audit-selection methods, auditor training, and state-by-state totals distinguishing affiliated and unaffiliated organizations. They also seek detailed Kentucky, Mississippi, and Florida audit records. The general records period begins July 22, 2026. Requested staff briefings are due October 30; requested documents are due November 6.234

Maintain a record that can answer the questions

Chad’s analysis: Maintain a chronology connecting each notice, receipt date, stated deadline, requested record, response, and outcome. Document staff time and operational disruption separately from disputed financial findings. That record can support an assessment of patterns without treating timing alone as proof of motive. Continue tracking existing response deadlines while following the inquiry. A congressional investigation should prompt careful documentation, not an assumption that an individual audit has been resolved.

Source notes

  1. H. Comm. on Oversight & Gov’t Reform, Comer Investigates PBMs for Retaliatory Audits of Independent Pharmacies (Oct. 23, 2026).
  2. Letter from James Comer, Chairman, H. Comm. on Oversight & Gov’t Reform, to Ed DeVaney, Exec. Vice President & President, CVS Caremark, at 1–3 (Oct. 23, 2026).
  3. Letter from James Comer, Chairman, H. Comm. on Oversight & Gov’t Reform, to Adam Kautzner, President, Express Scripts, at 1–3 (Oct. 23, 2026).
  4. Letter from James Comer, Chairman, H. Comm. on Oversight & Gov’t Reform, to Patrick Conway, Chief Exec. Officer, Optum Rx, at 1–3 (Oct. 23, 2026).